Gastric Cancer News
Afinitor Promising in Treatment of Advanced Gastric Cancer (July 23, 2010)Afinitor® (everolimus) may be a promising treatment option for patients with metastatic gastric cancer who have undergone previous treatment, according to a study published in the Journal of Clinical Oncology. Afinitor is an oral targeted therapy that... Continue Reading
Clinical Trial for Advanced Gastric Cancer Now Enrolling Patients (July 16, 2010)Gastric cancer forms in the tissues and lining of the stomach. Current treatment options include surgery, chemotherapy, and radiation. The current standard of care for metastatic gastric cancer is systemic therapy. Research is ongoing to determine which... Continue Reading
High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)High levels of vitamin D in the bloodstream do not appear to reduce the risk of seven less common cancers: endometrial, esophageal, stomach, ovarian, pancreatic, kidney, and non-Hodgkin’s lymphoma. In fact, there was a suggestion that people with the... Continue Reading
Depression May Persist With Metastatic Cancer (May 27, 2010)A substantial number of patients with metastatic cancer may suffer from depression which tends to persist and grow more severe toward the end of life, according to the results of a study published early online in the Journal of Clinical Oncology.[1] While... Continue Reading
Genetic Variant Associated with Poor Outcome for Gastric Cancer (May 24, 2010)Patients with gastric cancer who have a certain type of inherited variation in the CD44 gene experience a significantly shorter time to disease recurrence (2.1 years) compared with patients without the genetic variation (seven years), according to the... Continue Reading
Adjuvant Chemotherapy Clinical Trial Data from Last 30 Years Evaluated to Determine Benefit in Gastric Cancer (May 14, 2010)A moderate but statistically significant survival benefit was reported with the addition of chemotherapy to surgery in patients with resectable gastric cancer (gastric cancer that can be surgically removed). These findings were recently published in... Continue Reading
Cancers of the Lower Stomach have Increased in Young Whites (May 7, 2010)Although overall rates of noncardia gastric cancer (cancer of the lower stomach) have decreased in the United States, rates have increased in whites between the ages of 25 and 39 years. These findings were recently published in the Journal of the American... Continue Reading
Avastin Fails to Prolong Survival in Stomach Cancer (February 25, 2010)Avastin® (bevacizumab) in combination with chemotherapy does not extend overall survival in patients with inoperable, advanced or metastatic stomach cancer, according to the results of a phase III trial released by Roche.[i] Stomach cancer, also known... Continue Reading
Herceptin Improves Outcome of HER2-positive Stomach Cancer (October 3, 2009)According to the results of a Phase III clinical trial, treatment with the targeted therapy Herceptin® (trastuzumab) improves survival among patients with HER2-positive, advanced and inoperable stomach cancer. These results were presented at a major... Continue Reading
Aspirin May Reduce Risk of Stomach Cancer (August 28, 2009)Regular aspirin use may reduce the risk of distal stomach cancer (cancer in the lower part of the stomach). These results were published in the American Journal of Epidemiology. Cancer of the stomach is called gastric cancer. Gastric adenocarcinoma is... Continue Reading
Latest Gastric Cancer News By Stage
Recurrent Gastric Cancer
Clinical Trial for Advanced Gastric Cancer Now Enrolling Patients (July 16, 2010)
Gastric cancer forms in the tissues and lining of the stomach. Current treatment options include surgery, chemotherapy, and radiation. The current standard of care for metastatic gastric cancer is systemic therapy. Research is ongoing to determine which... Continue Reading
Herceptin® Improves Survival with HER2-positive Gastric Cancer (June 2, 2009)Herceptin® Improves Survival with HER2-positive Gastric Cancer According to the results of a Phase III clinical trial presented at the 2009 annual meeting of the American Society of Clinical Oncology (ASCO), treatment with a combination of chemotherapy... Continue Reading
More Recurrent Gastric CancerScreening/Prevention Gastric Cancer
High Circulating Vitamin D Levels Don’t Reduce Risk of Less Common Cancers (July 13, 2010)
High levels of vitamin D in the bloodstream do not appear to reduce the risk of seven less common cancers: endometrial, esophageal, stomach, ovarian, pancreatic, kidney, and non-Hodgkin’s lymphoma. In fact, there was a suggestion that people with the... Continue Reading
Cancers of the Lower Stomach have Increased in Young Whites (May 7, 2010)Although overall rates of noncardia gastric cancer (cancer of the lower stomach) have decreased in the United States, rates have increased in whites between the ages of 25 and 39 years. These findings were recently published in the Journal of the American... Continue Reading
Aspirin May Reduce Risk of Stomach Cancer (August 28, 2009)Regular aspirin use may reduce the risk of distal stomach cancer (cancer in the lower part of the stomach). These results were published in the American Journal of Epidemiology. Cancer of the stomach is called gastric cancer. Gastric adenocarcinoma is... Continue Reading
Fruits and Vegetables Reduce Risk of Stomach Cancer (March 8, 2009)Fruits and Vegetables Reduce Risk of Stomach Cancer According to an article recently published in the American Journal of Epidemiology, diets higher in vegetables and fruits and lower in foods common in Western diets (such as processed meats, soft drinks,... Continue Reading
More Screening/Prevention Gastric CancerStages I-II Gastric Cancer
Genetic Variant Associated with Poor Outcome for Gastric Cancer (May 24, 2010)
Patients with gastric cancer who have a certain type of inherited variation in the CD44 gene experience a significantly shorter time to disease recurrence (2.1 years) compared with patients without the genetic variation (seven years), according to the... Continue Reading
Adjuvant Chemotherapy Clinical Trial Data from Last 30 Years Evaluated to Determine Benefit in Gastric Cancer (May 14, 2010)A moderate but statistically significant survival benefit was reported with the addition of chemotherapy to surgery in patients with resectable gastric cancer (gastric cancer that can be surgically removed). These findings were recently published in... Continue Reading
Combination of Chemotherapy and Immunotherapy Shows Promise for Gastric Cancer (March 8, 2009)Combination of Chemotherapy and Immunotherapy Shows Promise for Gastric Cancer A combination of chemotherapy and immunotherapy (chemoimmunotherapy) may improve overall survival among gastric cancer patients. These findings were recently published in the... Continue Reading
Identification of Cellular Enzymes May Predict Prognosis of Gastric Cancer (March 8, 2009)Identification of Cellular Enzymes May Predict Prognosis of Gastric Cancer An important enzyme known as histone deacetylase may contain useful information about the prognosis of gastric cancer. These findings were recently published in the Lancet. Enzymes... Continue Reading
Removal of More Lymph Nodes May Improve Survival in Gastric and Pancreatic Cancers (March 8, 2009)Removal of More Lymph Nodes May Improve Survival in Gastric and Pancreatic Cancers Researchers recommend that at least 15 lymph nodes be removed and examined in patients with early gastric or pancreatic cancers. These results were recently published in... Continue Reading
More Stages I-II Gastric CancerStages III-IV Gastric Cancer
Afinitor Promising in Treatment of Advanced Gastric Cancer (July 23, 2010)
Afinitor® (everolimus) may be a promising treatment option for patients with metastatic gastric cancer who have undergone previous treatment, according to a study published in the Journal of Clinical Oncology. Afinitor is an oral targeted therapy that... Continue Reading
Clinical Trial for Advanced Gastric Cancer Now Enrolling Patients (July 16, 2010)Gastric cancer forms in the tissues and lining of the stomach. Current treatment options include surgery, chemotherapy, and radiation. The current standard of care for metastatic gastric cancer is systemic therapy. Research is ongoing to determine which... Continue Reading
Depression May Persist With Metastatic Cancer (May 27, 2010)A substantial number of patients with metastatic cancer may suffer from depression which tends to persist and grow more severe toward the end of life, according to the results of a study published early online in the Journal of Clinical Oncology.[1] While... Continue Reading
Avastin Fails to Prolong Survival in Stomach Cancer (February 25, 2010)Avastin® (bevacizumab) in combination with chemotherapy does not extend overall survival in patients with inoperable, advanced or metastatic stomach cancer, according to the results of a phase III trial released by Roche.[i] Stomach cancer, also known... Continue Reading
Herceptin Improves Outcome of HER2-positive Stomach Cancer (October 3, 2009)According to the results of a Phase III clinical trial, treatment with the targeted therapy Herceptin® (trastuzumab) improves survival among patients with HER2-positive, advanced and inoperable stomach cancer. These results were presented at a major... Continue Reading
More Stages III-IV Gastric Cancer